Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinoril for Breast Density and AI-Associated Pain
NCT01761877Phase 2Completed
- Sponsor
- Stony Brook University
- Start
- Dec 2012
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulindac in breast cancer, arthralgia, sponsored by Stony Brook University. Started Dec 2012; status: completed.
02
Drugs
sulindac
03
Conditions
breast cancerarthralgia
Beyond the preview
Go deeper on NCT01761877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761877.